TSH receptor mutants in the VI transmembrane segment, found in thyroid autonomously functioning adeonomas, have been expressed in dierentiated thyroid cells. All mutant receptors constitutively stimulated adenylyl cyclase. The biological activity, measured as cAMP production relative to the wild type receptor, was speci®c for each mutant in transient and stable transfection assays. Cells expressing these mutants proliferated in the absence of TSH. The rate of growth in the absence of TSH paralleled basal cAMP production for each mutant receptor. Low TSH concentrations stimulated the growth of mutant receptor-expressing cells, and not of the cells expressing the wild type receptor. Also, the entry in the cell cycle and the plating eciency were markedly stimulated by the expression of the mutant receptors. These data provide a molecular link between the occurrence of TSH receptor mutations and thyroid autonomously functioning adenomas.
Introduction
The hormone thyrotropin stimulates the growth and the dierentiation of thyroid gland. The hormone recognizes a speci®c receptor on the surface of thyrocytes and triggers via the heterotrimeric guanine nucleotide binding proteins (G-protein) the activation of adenylyl cyclase and other eectors. cAMP is the principal second messenger in thyroid cells. cAMP and agents which increase cAMP stimulate the expression of thyroid speci®c genes, the uptake of iodine, the synthesis, the secretion of thyroid hormones and the growth of thyroid cells (Weiss et al., 1984; Vassart and Dumont, 1992; Avvedimento et al., 1984) .
TSH receptor belongs to a broad class of G-protein coupled receptors named serpentine or seven-loop receptors because the molecule crosses seven times the plasma membrane. The basic structure of these receptors shows the presence of three domains: a large extracellular segment at the N-terminus, which represents the hormone-binding site, three intracellular loops, and seven intramembrane helices. These two latter domains are thought to be critical for coupling and signalling to the heterotrimeric G-proteins (Cotecchia et al., 1990; Lefkovitz, 1993) .
Thyroid autonomously functioning adenomas are clonal neoplasms characterized by autonomous growth and secretion of thyroid hormones (Maenhaut et al., 1991) . A molecular basis for the TSH-independent growth and function of these tumours has been recently found: some of these tumours have somatic mutations in the alpha subunit of heterotrimeric G-protein (G s a) coupled to the TSH receptor, which stimulates the adenylyl cyclase (Lyons et al., 1990; O'Sullivan et al., 1991; Suarez et al., 1991) . In other cases of thyroid hyperfunctioning adenomas activating mutations of the TSH receptor have been found in the III8 intracellular loop of the receptor (Parma et al., 1993) .
We have recently reported four independent mutations clustered in the VI transmembrane spanning segment of the TSH receptor in 11 cases of autonomously functioning thyroid adenomas (Porcellini et al., 1994) . A germ-line mutation located in the same domain of the receptor has also been reported in a case of congenital hyperthyroidism (Kopp et al., 1995) .
These receptors expressed in heterologous systems constitutively stimulate adenylyl cyclase and cAMP signalling (Paschke et al., 1994; Porcellini et al., 1995; Parma et al., 1995) . To date, however, there is no indication as to the biological properties in vivo of these mutants in the context of thyroid cells.
We have stably integrated and expressed the mutant TSH receptors in dierentiated thyroid cells and we have found that these cells express eciently thyroid speci®c genes and become TSH-independent for the growth recapitulating the biological features of thyroid autonomously functioning adenomas.
Results

Expression of human TSH receptor mutants in rat thyroid cells
The growth of the rat thyroid cell line (FRTL-5 line) is tightly dependent on the presence of TSH in the culture medium (Ambesi-Impiombato et al., 1980; Bidey et al., 1988; see Materials and methods) . These cells have been transfected with DNA expression vectors encoding the wild type and four dierent versions of TSH receptor mutated in three residues located in the VI intramembrane loop, previously isolated from thyroid autonomously functioning adenomas (Porcellini et al., 1994 (Porcellini et al., , 1995 Paschke et al., 1994) . Stable expressing clones, grown in the presence of TSH, were selected in a medium containing puromycin. After 20 days the puromycin-resistant clones were pooled (ca. 20 for each mutant) and further analysed.
TSH receptor gene expression was measured by Northern blot analysis using as probe a cDNA fragment encoding the NH-terminal segment of the extracellular domain of the human receptor. All clones expressed the exogenous receptor mRNA corresponding to a transcript of ca. 4.5 kb ( Figure  1 ). The endogenous receptor was not detectable in the blot shown in Figure 1 . The heterologous probe and the lower concentration of the speci®c mRNA in TSH-grown cells probably account for the absence of the endogenous TSH receptor mRNA band (Tramontano and Ingbar, 1986; Saji et al., 1992; Akamizu et al., 1990) . The variation in the expression of the mutant receptors among the dierent pools of transfected cells was ca. 0.6 ± 1.5 relatively to the wild type expressing cells. The morphology of clones expressing human TSH receptor gene was unchanged relative to parental cells. Thyroglobulin mRNA accumulation was comparable among the clones analysed, except in cells expressing the T632I mutant, which showed a twofold reduction ( Figure  1 ). At present we do not know if this reduction of thyroglobulin mRNA was present in the original tumour carrying the mutation.
To monitor the expression of functional receptors on the cell surface, we analysed the binding of radiolabelled TSH ([   125   I ]TSH, 70 mCi/mg, Dupont, USA) to transfected cells. We detected speci®c binding of labelled TSH in transfected cells and we did not ®nd dierences in the binding ability among cell clones expressing the various versions of the receptor (data not shown). However, this assay was not very sensitive due to low number of endogenous and exogenous receptors in stably transfected thyroid cells compared to COS-7 transient expression system (Gorman et al., 1983; Aruo and Seed, 1987; Avvedimento et al., 1988) .
In the absence of TSH all the TSH receptor mutantexpressing cells showed high cAMP content, relative to the wild type TSH receptor (Figure 2a ). The mutant T632I contained cAMP levels signi®cantly higher (2.5-fold higher) than the other mutants ( Figure 2a) . We have compared the ability of the mutant receptors to stimulate adenylyl cyclase with that of the wild type receptor in a transient expression assay (COS-7 cells) and in a stable population of thyroid cells carrying integrated copies of the transfected receptors. Note that the copy number of expressed receptors was signi®cantly higher in transient than in stable expression system (Gorman et al., 1983; Aruo and Seed, 1987; Avvedimento et al., 1988) . Figure 2b shows that the relative increase in cAMP levels determined by the expression of the mutant receptors was remarkably similar in transient and in stable transfection assays. The absolute accumulation of cAMP was dependent on the amount of transfected DNA. Thus, the number of receptors increased linearly with the amount of transfected DNA (Porcellini et al., 1995; Paschke et al., 1994) . By comparing several experimemts with dierent cell lines and dierent amounts of DNA we have concluded that the stimulation of cAMP levels of each mutant receptor relative to the wild type receptor (set arbitrarily to 1) is remarkably constant. It is worth noting that Figure 2b compares the relative activity and not the absolute potency in stimulating adenylyl cyclase of the transfected receptors. These data indicate that the relative stimulation of cAMP levels by dierent TSH receptor mutants is dependent on the type of receptor expressed.
We have also measured cAMP accumulation in mutant-expressing cells in the presence of various TSH concentrations. Figure 3 shows that low TSH (0.1 mU/ ml) signi®cantly stimulated cAMP in T632I and D633Y, at lesser extent in D633E cells. Wild typeexpressing cells and the F631C mutant did not respond to these TSH concentrations (Figure 3a) . At TSH concentrations used in vivo for FRTL-5 cultures (1 mU/ml) both the wild type and F631C increased cAMP levels at levels found in other TSH mutantexpressing cells (Figure 3b ). Also at these TSH concentrations the T632I mutant showed the most ecient response. At higher TSH (10 mU/ml) concentrations, the dierences among the mutants and Table 1 summarizes the activity of the mutant receptors. These data indicate that cells expressing TSH receptor mutants respond more eciently to low TSH concentrations than the cells expressing the wild type receptor.
TSH-independent growth of thyroid cells expressing the mutant TSH receptors
In the absence of TSH, mock-transfected cells or cells expressing the wild type receptor did not grow (Figure 4) . Cells expressing the various TSH receptor mutants proliferated in the absence of TSH in the medium (Figure 4 ). T632I cells showed the fastest growth rate Relative cAMP accumulation in cells transiently and stably expressing human wild type TSH receptor and the various mutants. COS-7 cells were transiently transfected with 1, 2 and 3 mg of plasmid DNA encoding for the wild type and the various TSH receptor mutants. cAMP accumulation was measured, the background corresponding to mock transfected cells subtracted in each experimental condition and the value found in wild type expressing cells was arbitrarily set to 1. FRTL-5 cells were stably transfected as indicated above. cAMP levels were measured in each transfected pool and the value in wild type expressing cells was arbitrarily set to 1. This experiment was repeated three times in triplicate samples relative to the other receptor mutants (Figure 4 lower inset).
Addition of TSH to the medium stimulated the growth of control cells and wild type TSH receptorexpressing cells. Low TSH concentrations (0.1 mU/ml) vigorously stimulated the proliferation of all mutant receptor-expressing cells relative to control and wild type-expressing cells (cfr 3 to 6 days in the presence of 0.1 mU/ml of TSH in Figure 5a ). This eect was more evident at day 3 and 6 from TSH addition. Later, the proliferation curves of the cells expressing the mutant receptors became very similar, indicating a`priming' eect of TSH in cells expressing the mutant receptors. At higher TSH concentrations (1 mU/ml) also the growth of wild type receptor-expressing cells was stimulated by the hormone (Figure 5b ). Control cells, expressing only the endogenous receptor, proliferated less than the cells expressing the mutant or the wild type receptor. These clones, for example, needed 48 or 90 additional hours (out of 6 days) to reach the same number of cells of the clones expressing the wild type or the mutant receptor, respectively (Figure 5b ). The dierences outlined above are evident in the logarithmic phase of growth (Figure 5c and d) .
The dierences in the growth rate between control cells and wild type receptor transfected cells can be better explained by the lack of regulation of the exogenous receptor transcription driven by the viral promoter. In the presence of 1 mU/ml TSH the endogenous receptor was suppressed, while the exogenous was not (Figure 1 and Tramontano and Ingbar, 1986; Saji et al., 1992; Akamizu et al., 1990) . However, overexpression of unregulated wild type receptor did not eliminate the dierences in the growth rate between wild type receptor and mutant receptors-expressing cells (Figure 5b and d) .
To determine more precisely the eects of TSH receptor mutants in thyroid cells, we analysed cell cycle progression and DNA synthesis by [ 3 H]thymidine incorporation. We starved the cells from serum and TSH for 3 days and forced them into quiescence. Note that TSH starvation alone did not synchronize transfected cells, since they proliferated in the absence of TSH. Addition of TSH and insulin to the medium induced entry in the cycle and DNA synthesis. Figure 6 shows that the clones expressing the wild type and the mutant versions of the receptor entered S phase 36 h after TSH stimulation, while mock-transfected cells expressing only the endogenous receptor or differentiated FRTL-5 started S phase 48 h after TSH stimulation (Jin et al., 1986; Tramontano et al., 1988) . Cells expressing the TSH receptor mutant D633Y entered the S phase 24 h after TSH stimulation ( Figure 6 ). These cells, however, did not proliferate better than the other mutant-expressing cells, indicating that another phase of the cycle compensated a shorter G1 ( Figure 5 ). Cell cycle analysis by¯uorescence activated cell sorter did not reveal any substantial change in G2-M or M phases (data not shown).
The data shown above indicate that the overexpression of the wild type receptor per se induced anticipation of the S phase onset. This ®nding might explain why these cells proliferated better than mocktransfected cells (Figures 4 and 5) .
We also analysed the ability to form colonies of the cells expressing the wild type and the mutant receptors. Ca. 200 cells expressing the various TSH receptors Figure 4 Growth of wild type and mutant TSH receptor expressing cells in the absence of TSH. Cells were seeded in the presence of TSH and grown in a medium deprived of the hormone. Lower panel indicates the number of cells in various samples at day 15 in the absence of TSH. This experiment was repeated at least three times in triplicate samples were seeded in a 6 multiwell system in the presence of TSH. Twenty-four hours later TSH was removed or lowered to 0.1 mU/ml. Thirty days later the clones were counted and their cellularity was evaluated by contrast microscopy. In the absence of TSH only mutant-expressing cells formed visible clones while neither wild type-expressing cells nor mock-transfected cells did so. In the presence of 0.1 mU/ml TSH also wild type receptor-expressing cells formed visible colonies, albeit less than mutant receptors-expressing clones. Control cells expressing only the endogenous receptor were unable to form visible colonies in the presence of 0.1 mU/ml TSH (Figure 7 ).
These data indicate that the plating eciency in the absence of TSH was signi®cantly stimulated in mutant receptor-expressing cells. This was not caused by the overexpression of unregulated receptor because wild type receptor-expressing cells did not form visible colonies in the absence of TSH (Figure 7 ).
Discussion
The data presented here indicate that dierent and continguous mutations in the seventh loop of the TSH receptor, expressed in thyroid cells, confer TSH- Figure 5 Growth of wild type and mutant receptor expressing cells in 0.1 and 1 mU/ml TSH. Cells were seeded in the presence of TSH and 24 h later TSH was withdrawn from the medium. (a) TSH 0.1 mU/ml; (b) 1 mU/ml; (c and d) represent the cell number of the various samples at day 6 from TSH addition independent growth. These mutations have been found in vivo in thyroid autonomously functioning adenomas, which are TSH-independent clonal neoplasms. All mutants analysed here activated constitutively adenylyl cyclase (Figure 2a) . The relative potency in activating adenylyl cyclase was dependent on the type of mutation and not on the speci®c transfected clone. The relative potency of each mutant was comparable and independent on the assay system used (Figure 2b) .
The mutations of the receptor analysed here are contiguous in the seventh transmembrane loop of the protein. To date, the biological activity of these mutants has been analysed by transient transfection in COS-7 or 3T3 cells (Parma et al., 1993 Porcellini et al., 1994 Porcellini et al., , 1995 Paschke et al., 1994) . Under these conditions the potency of the receptors was measured as activation of endogenous adenylyl cyclase. Since cAMP stimulates the growth and the dierentiation of thyroid cells, it was concluded that TSH-independent growth of thyroid autonomous adenomas was caused by these somatic activating mutations, which increased the basal cAMP levels (Parma et al., 1993 Porcellini et al., 1994 Porcellini et al., , 1995 Kopp et al., 1995; Paschke et al., 1994) . This is the ®rst demonstration that these mutations of the receptor confer TSH independent growth when expressed in thyroid cells.
Cells expressing TSH receptor mutants are more sensitive to TSH
The growth rates of thyroid cells expressing the wild type or the various receptor mutants were very similar in the presence of high TSH concentrations (Figure 5b (Figure 5a and c). In the absence of TSH only the mutant receptorexpressing cells proliferated (Figure 4 ). Comparing the potency of the activation of adenylyl cyclase and the growth rate in the absence (Figures 2 and 4 ) or in presence of low TSH concentrations (Figures 3a, 5a and c), the mutant receptor-expressing cells showed a greater sensitivity to TSH, relative to the wild type receptor. Furthermore, we noticed a 6-day lag period before the onset of logarithmic phase in the proliferative pro®le of control or wild type receptorexpressing cells in the presence of low TSH (0.1 mU/ ml (Figure 5a ). This lag was reduced in TSH mutant receptor-expressing cells grown in the same conditions, indicating a greater sensitivity to TSH of these cells (Figure 5a ). Higher sensitivity to TSH can be caused either by increased anity to the hormone of the mutated receptors or by a low threshold in the activation state of the mutant, relative to the wild type receptor. We did not ®nd dierences in the anity of the mutant receptors to the hormone relative to the wild type receptor (data not shown; Porcellini et al., 1995; Paschke et al., 1994) . However, cells expressing these mutant receptors were more sensitive to the hormone than cell expressing the wild type or the endogenous receptors. We suggest that the activation state of the receptor is signi®cantly stimulated in the mutant versions (Figure 2 and Bond et al., 1995) .
Overexpression of wild type receptor signi®cantly stimulated proliferation and anticipated the peak of DNA synthesis in the presence of 1 mU/ml TSH (Figures 5b and 6 ). These eects can be explained by: (I) higher number of the receptors, relative to mocktransfected cells ( Figure 1) ; (II) loss of regulation of the exogenous receptor, which constitutively maintain higher cAMP levels in the presence of 1 mU/ml TSH (Figure 3) .
Dierences in the biological activity of the mutant receptors
The mutant receptors did not behave similarly. Signi®cantly, either in transient or stable expression assays, the relative ability of mutated receptors to stimulate adenylyl cyclase was not the same, being T632I the most potent and D633Y the less eective (Figure 2) . The relative potency of the mutant receptors, measured either by basal cAMP accumulation or by stimulation of proliferation or plating eciency in the absence of TSH was maintained in the presence of low or intermediate concentrations of TSH (Figures 3, 5 and 7) . The mutant D633Y responded very eciently to 0.1 mU TSH as cAMP production and was very eective in stimulating the growth in the absence of TSH (Figures 3a and 4) . Comparative analysis of the data presented above indicates a remarkable overlap between the ability to stimulate cAMP levels, the proliferation and the These ®ndings suggest that the mutated receptor confers a precise growth advantage when expressed on the surface of the cell in the absence or at low concentrations of TSH. Under these conditions (0 to 0.1 mU/ml TSH) cells expressing the wild type receptor do not grow, while cells expressing the mutated receptor do. We predict that these mutations of the receptor might induce dierent clinical phenotypes.
Alterations of the cell cycle progression in cells expressing the wild type and the mutant TSH receptors
Growth is a complex and pleiotropic process which can be altered by dierent events. Expression of TSH receptors driven by a constitutive promoter might induce growth alterations per se. We have monitored such type of eects caused by the lack of regulation of the exogenous receptors, by expressing the wild type receptor under the same promoter used for the expression of the mutant receptors.
Cell cycle analysis indicated that expression of the wild type receptor as well as of the mutant versions of the TSH receptors resulted in the shortening of G1. Cells expressing only the endogenous receptor entered S phase 48 h after TSH initial stimulation ( Figure 6 and Jin et al., 1986; Tramontano et al., 1988 and AP, unpublished observations) . This eect was dependent on either the absence of regulation or overexpression of the wild type receptor and not by the mutations per se. Even though cAMP levels are downregulated by activated PDE-IV during the progression in the cycle (Sette et al., 1994) , persistent high copies of receptor might activate constitutively adenylyl cyclase. The wild type receptor constitutively activates adenylyl cyclase when overexpressed (Paschke et al., 1994; Porcellini et al., 1995; Parma et al., 1995) , suggesting that sustained cAMP levels, induced by wild type receptor or by the mutant versions of the receptor, in thyroid cells accelerate the entry in the cycle. The data presented are consistent with a`priming' eect of constitutive activated receptors in cells entering the cycle and can explain why these cells proliferate better than control cells at low TSH concentrations (Figure 5a ).
The mutant D633Y appears to be peculiar, since it signi®cantly accelerates the entry in S phase (Figure 6 ). This mutant responded very eciently to 0.1 mU/ml TSH as did T632I, but did not stimulate the proliferation as well as T632I, which appeared the most potent receptor in activating both adenylyl cyclase and growth (Figure 3a) . Cell cycle analysis did not indicate any other alteration in the cycle phases, suggesting that only the transition G0 to early G1 might be aected by the mutant receptor. This eect can be detected only in the ®rst cycle from quiescence to S phase and not in growing cells.
In conclusion we have provided evidence of the biological eects in thyroid cells of mutations in the VI transmembrane domain of TSH receptor, which recapitulate in vitro the features of thyroid autonomously functioning adenomas: TSH-independent growth, constitutive activation of adenylyl cyclase and increased sensitivity to TSH. These data provide a tight molecular link between the occurrence of these mutations and the clinical phenotype of thyroid autonomously functioning adenomas.
Materials and methods
Plasmids and transfections
Cells were grown in F12 medium with 5% calf serum and ®ve hormones (1 mg/ml Insulin, 3.6 mg/ml Hydrocortisone, 5 mg/ml Transferrin, 10 ng/ml Somatostatin, 20 mg/ml Glycil-istidil-lysin). In some experiments TSH was not added (no TSH medium); in others 0.1 mU/ml (low TSH medium) or 1 mU/ml (normal medium) TSH was added to the hormones mixture. TSH used was from Sigma. We have experienced a sign®cant variability in the TSH preparations, which varied from lot to lot. To reduce such variations we have used fresh and not aged FRTL-5 cells (less than 10 continuous passages) and we have estimated that 1 mU/ml of our TSH preparations corresponds to ca. 100 pM.
Cloning of the TSH receptor mutants in a plasmid expression vector carrying the resistance to puromycin (pBabe-puro) has been previously described (Porcellini et al., 1994) . The plasmid constructs were stably transfected in dierentiated thyroid FRTL-5 cells (Ambesi-Impiombato et al., 1980; Bidey et al., 1988) . Five ± ten mg of the appropriate expression vector were stably transfected by the calcium phosphate procedure (Sambrook et al., 1989) .
One mg/ml puromycin was added to the transfected cells and ca. 20 puromycin-resistant clones were obtained for each transfection. Clones (ca. 20 for each construct) were pooled and further analysed.
FRTL-5 (US patent 4 608 341; US patent 4 609 622) used in this study have been extensively characterized for TSHindependent growth and in vivo tumorigenesis (Avvedimento et al., 1989 (Avvedimento et al., , 1991 Gallo et al., 1992) .
RNA analysis
Total RNA was extracted from 2610 7 cells grown in 150 mm 1 dish in the presence of 1 mU/ml of TSH by guanidium isothiocyanate method (Chomczynski and Sacchi, 1987) . Twenty micrograms of each RNA sample was electrophoresed on 1% agarose gel containing formaldehyde and transferred to nylon membranes (Amersham) using standard capillary techniques (Sambrook et al., 1989) . The ®lter was hybridized with speci®c radioactive probes 15 h at 658C in the buer containing 0.5 M Na 2 PO 4 pH 7.2, 7% SDS, 1 mM EDTA. Radioactivity was revealed by autoradiography using pre¯ashed ®lms.
The following cDNA probes were used: (1) 0.9 kb DNA fragment corresponding to human TSH-R cDNA region coding for codons 58 to 381; (2) a cDNA fragment 1759 bp long corresponding to the 5' end of rat thyroglobulin mRNA; (3) the complete rat GAPDH cDNA. All probes were labelled with [ 32 P] by Random Primer method. Quantitative analysis of the human TSH-R mRNA amount was performed by densitometry using the NIH Image software for Apple Macintosh.
cAMP assays
For each experimental point 600 000 cells per clone were seeded on 35 1 mm dish; after 48 h they were starved from TSH and serum for 16 h; then serum free medium with 0.5 mM IBMX and dierent TSH concentrations (0, 0.1, 1.0 and 10 mU/ml) was added for 20 ± 40 min. Cells were then lysed with cold ethanol containing 1% 1 M HCl and kept over night at +48C. The medium was taken and neutralised, lyophilised and resuspended in 0.2 ml of 10 mM Tris HCl pH 7.8 1 mM EDTA and used for cAMP assay (Amersham, cyclic AMP [ 3 H]assay system). This experiment was repeated three times in triplicate samples. Under these conditions mock-transfected cells do not respond eciently to 0.01 ± 0.1 mU/ml TSH (cAMP accumulation after 20 min in 0.01 and 0.1 mU/ml of TSH was 105+9% and 113+10% over the basal, respectively).
Growth studies
Proliferation was studied in dierent conditions: normal medium, low TSH and no TSH medium as indicated above. For each experiment 10 000 cells of each clone were seeded in a 12 multiwell system; cells were taken and counted after 24 h, 3, 6, 9 and 15 days.
For plating eciency experiments 200 cells were seeded in six multiwell systems, after 30 days clones were stained with 0.25% Cromassie Brilliant Blue in methanol and 10% acetic acid. Visible clones were counted and the cellularity was analysed by phase contrast microscopy.
[ 3 H]thymidine incorporation studies were done as follows: 50 000 cells were seeded in 24 multiwell systems, after 24 h cells were starved from TSH and serum for 72 h; then stimulation with 1 mU/ml TSH and 1 mg/ml Insulin was added. Three hours before taking the cells [ 3 H]thymidine was added to the medium; cells were taken 0, 12, 24, 36, 48, 72 h after stimulation. DNA was extracted by Cell Harvester. The speci®c radioactivity was measured by scintillation counting. Each experiment was repeated at least three times in triplicate samples.
Cell cycle phases analysis was carried out by FACS. Cells were seeded in the presence of the complete medium for 48 h and then were subjected to the speci®c treatments described in the text.
